Concarlo Holdings is Biotechnology in United States that focus on diagnostic evaluations business. Founded in 2015. They cover business area such as developer, novel therapeutic, breast cancer management, patent technology, drug efficacy, diagnostic evaluation, cancer patient, drug resistance issue, metastatic breast cancer.
2015
( 9 years old in 2024 )
Diagnostic Evaluations
-
Downstate Biotechnology Incubator
760 Parkside Avenue, Room 208
New York, NY 11226
United States
Private
developernovel therapeuticbreast cancer managementpatent technologydrug efficacydiagnostic evaluationcancer patientdrug resistance issuemetastatic breast cancer
* We use standard office opening hours in near Concarlo Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Concarlo Holdings is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Concarlo Holdings business is focusing on Diagnostic Evaluations.
Concarlo Holdings headquarter office and corporate office address is located in Downstate Biotechnology Incubator 760 Parkside Avenue, Room 208 New York, NY 11226 United States.
Concarlo Holdings was founded in United States.
In 2024, Concarlo Holdings is currently focus on diagnostic evaluations sector.
Above is snippet of Google Trends for "diagnostic evaluations" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Concarlo Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
